NASDAQ: PTGX - Protagonist Therapeutics, Inc.

Yield per half year: +18.83%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Protagonist Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Protagonist Therapeutics, Inc.

Биофармацевтическая компания Protagonist Therapeutics, Inc. разрабатывает препараты на основе пептидов для лечения гематологии и заболеваний крови, а также воспалительных и иммуномодулирующих заболеваний.

more details
Он разрабатывает русфертид (PTG-300), инъекционный миметик гепсидина, который проходит фазу II клинических испытаний для лечения эритроцитоза, перегрузки железом и других заболеваний крови; и JNJ-2113, пероральное исследуемое лекарство для блокирования биологических путей, которое проходит фазу II клинических испытаний для лечения бляшечного псориаза средней и тяжелой степени; и PN-943, перорально доставляемый, ограниченный кишечником альфа-4-бета-7-специфический антагонист интегрина, который проходит фазу II клинических испытаний при воспалительном заболевании кишечника. У компании есть лицензия и соглашение о сотрудничестве с Janssen Biotech, Inc. Protagonist Therapeutics, Inc. была зарегистрирована в 2006 году и имеет штаб-квартиру в Ньюарке, Калифорния.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2016-08-11
ISIN US74366E1029
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.protagonist-inc.com
Цена ао 54.9
Change price per day: 0% (54.9)
Change price per week: +43.16% (38.35)
Change price per month: +46.71% (37.42)
Change price per 3 month: +33.64% (41.08)
Change price per half year: +18.83% (46.2)
Change price per year: +89.44% (28.98)
Change price per 3 year: +115.21% (25.51)
Change price per 5 year: +539.12% (8.59)
Change price per 10 year: 0% (54.9)
Change price per year to date: +35.22% (40.6)
All parameters

Underestimation

Title Value Grade
P/S 5.77 2
P/BV 3.71 5
P/E 9.11 9
EV/EBITDA 9.57 8
Total: 7.63

Efficiency

Title Value Grade
ROA, % 49.91 10
ROE, % 54.39 10
Total: 6.67

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0.043 10
Total: 8

Growth impulse

Title Value Grade
Yield Revenue, % 1417.51 10
Yield Ebitda, % -497.16 0
Yield EPS, % -319.88 0
Total: 2
More

ETFShare, %Profitability for 1 year, %Dividends, %
Invesco Biotechnology & Genome ETF 3.06436 26.49 0.16298
Invesco S&P SmallCap Health Care ETF 1.90772 10.25 0.41696
Invesco Dorsey Wright Healthcare Momentum ETF 1.78245 6.18 0.12263
Virtus LifeSci Biotech Clinical Trials ETF 1.08994 63.04 0.33
First Trust Small Cap Growth AlphaDEX Fund 0.77358 42.5 1.22182
Amplify Etho Climate Leadership U.S. ETF 0.55584 22.79 1.41942
Adaptive Alpha Opportunities ETF 0.44687 25.42 0.92229
First Trust Small Cap Core AlphaDEX Fund 0.3785 17.31 1.87983
Syntax Stratified SmallCap ETF 0.37273 13.51 1.639
JPMorgan Market Expansion Enhanced Equity ETF 0.30356 29.85 1.69513
Principal U.S. Small-Cap ETF 0.29365 16.7 1.20466
SPDR S&P 600 Small Cap Growth ETF 0.29022 14.13 1.33495
Direxion Daily S&P Biotech Bull 3x Shares 0.28398 4067.92 0.25924
Future Tech ETF 0.26928 426.34 0.8416
Principal Healthcare Innovators ETF 0.26928 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.25961 28.58 0.8565
Inspire Small/Mid Cap ETF 0.24197 28.65 1.92038
Donoghue Forlines Innovation ETF 0.21027 28.12 0.89556
SPDR Portfolio S&P 600 Small Cap ETF 0.204 13.05 1.84119
iShares Russell 2000 Growth ETF 0.20383 38.04 0.6026
Hartford Multifactor Small Cap ETF 0.19571 26.31 2.59467
Vanguard S&P Small-Cap 600 ETF 0.19 13.46 1.89226
Vanguard Russell 2000 Growth ETF 0.19 23.05 0.60264
ProShares Ultra Nasdaq Biotechnology 0.17456 51.7 0.85651
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.16663 24.75 1.59225
First Trust Multi Cap Growth AlphaDEX Fund 0.15724 41.56 1.02425
ProShares Ultra SmallCap600 0.14244 49.8 1.83727
Avantis U.S Small Cap Equity ETF 0.1395 27.77 1.68271
SPDR S&P 600 Small Cap Value ETF 0.1181 11.01 2.34209
iShares Morningstar Small-Cap Growth ETF 0.1117 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.1117 587.89 0.72598
Vanguard S&P Small-Cap 600 Value ETF 0.11 12.06 2.40883
Vanguard U.S. Momentum Factor ETF 0.1 30.05 1.05834
ETC 6 Meridian Quality Growth ETF 0.09921 30.05 0.77428
Vanguard Russell 2000 ETF 0.09 17.16 1.48801
Avantis U.S. Small Cap Value ETF 0.08066 29.3 2.3212
Schwab U.S. Small-Cap ETF 0.07251 17.47 1.51433
iShares ESG Aware MSCI USA Small-Cap ETF 0.0599 18.09 1.49366
ProShares UltraPro Russell2000 0.05975 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.05658 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.05658 30.1 1.60498
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.05361 31.36 1.41955
Fidelity MSCI Health Care Index ETF 0.03043 3 1.46057
ProShares Hedge Replication ETF 0.01598 5.92 1.47892
Avantis U.S. Equity ETF 0.01269 23.04 1.59151
Humankind US Stock ETF 0.00769 18.81 1.99919
Schwab U.S. Broad Market ETF 0.00528 24.86 1.43354
SPDR Portfolio S&P 1500 Composite Stock Market ETF 0.00513 24.29 1.46083
iShares Russell 3000 ETF 0.00507 24.83 1.43482
SPDR Portfolio MSCI Global Stock Market ETF 0.00442 17.99 2.19607
Dimensional US Core Equity Market ETF 0.00337 30.98 1.40618
Dimensional U.S. Equity ETF 0.00225 31.53 1.3557
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.3138.911.33



Head Job title Payment Year of birth
Dr. Dinesh V. Patel Ph.D. CEO, President, Secretary & Director 883.46k 1957 (68 years)
Dr. Suneel K. Gupta Ph.D. Chief Development Officer 640.89k 1958 (67 years)
Mr. Asif Ali Executive VP & Chief Financial Officer N/A 1974 (51 year)
Mr. Mohammad Masjedizadeh Ph.D. Executive VP & Chief Technical Officer N/A
Mr. Matthew M. Gosling Executive VP & General Counsel N/A 1971 (54 years)
Ms. Carena Spivey Head of HR & Senior VP of Human Resources N/A
Dr. Ashok Bhandari Ph.D. Executive VP & Chief Drug Discovery and Preclinical Development Officer N/A 1964 (61 year)
Mr. Carter J. King Executive Vice President of Business Development N/A 1971 (54 years)
Dr. Mark Smythe Ph.D. Founder & VP Technology N/A 1965 (60 years)
Ms. Abha Bommireddi Executive Vice President of Portfolio & Program Management N/A

Address: United States, Newark. CA -, 7707 Gateway Boulevard - open in Google maps, open in Yandex maps
Website: https://www.protagonist-inc.com